Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1974;43:54-56
© 1974 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRUDER, M. L.
Right arrow Articles by RENNINGER, C W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BRUDER, M. L.
Right arrow Articles by RENNINGER, C W

Dibromomannitol Therapy of Chronic Myelogenous Leukemia During Pregnancy

MURRAY L. BRUDER, MD, DAVID PRAGER, MD, FACP and C W RENNINGER, MD, FACOG

From the Department of Obstetrics and Gynecology and the Department of Medicine, Division of Hematology/Medical Oncology, Allentown Hospital, Allentown, Pennsylvania

Abstract

A case is presented in which a new chemotherapeutic agent, dibromomannitol, was used to treat a pregnant patient for chronic myelogenous leukemia from the 10th through the 17th week of gestation. At birth, and during the subsequent 4 years of followup, the patient's child has remained normal. The results obtained in this case are presented to aid other physicians in the evaluation and treatment of future cases of chronic myelogenous leukemia during a pregnancy in which the use of dibromomannitol is considered.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American College of Obstetricians and Gynecologists.